blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3672618

EP3672618 - COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.05.2022
Database last updated on 15.06.2024
FormerRequest for examination was made
Status updated on  29.05.2020
FormerThe international publication has been made
Status updated on  02.03.2019
Most recent event   Tooltip13.05.2022Application deemed to be withdrawnpublished on 15.06.2022  [2022/24]
Applicant(s)For all designated states
Nal Pharmaceutical Group Limited
Rooms 2906-08, 29/F, Windsor House
311 Gloucester Road
Causeway Bay, Hong Kong Sar. / HK
For all designated states
Mo, Y., Joseph
1 Belleview Terrace
Princeton, NJ 08540 / US
[2020/27]
Inventor(s)01 / MO, Y. Joseph
1 Belleview Terrace
Princeton, New Jersey 08540 / US
02 / YUAN, Xudong
29 Peregrine Dr.
Morganville, New Jersey 07751 / US
 [2020/27]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[2020/27]
Application number, filing date18848847.208.08.2018
[2020/27]
WO2018US45710
Priority number, dateUS201762550535P25.08.2017         Original published format: US 201762550535 P
[2020/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019040282
Date:28.02.2019
Language:EN
[2019/09]
Type: A1 Application with search report 
No.:EP3672618
Date:01.07.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 28.02.2019 takes the place of the publication of the European patent application.
[2020/27]
Search report(s)International search report - published on:US28.02.2019
(Supplementary) European search report - dispatched on:EP04.06.2021
ClassificationIPC:A61K38/16, A61K38/22, A61K47/42, G01N33/70, G01N33/546, C07K14/76, A61P35/00, A61K9/00, A61K31/00, A61K31/337, C07K14/655, A61K47/62
[2021/27]
CPC:
A61K9/5052 (EP,KR,US); A61K31/337 (EP,KR,US); A61K45/06 (US);
A61K47/02 (EP); A61K47/62 (EP); A61K47/6935 (EP);
A61K9/0019 (EP,KR); A61P35/00 (EP,KR); C07K14/00 (KR);
C07K14/76 (EP,KR); G01N33/546 (EP); C07K14/655 (EP);
C07K2319/00 (KR); C07K2319/31 (EP); G01N2333/765 (EP) (-)
Former IPC [2020/27]A61K38/16, A61K38/22, A61K47/42
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/27]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE ABGABE PHARMAKOLOGISCHER WIRKSTOFFE[2020/27]
English:COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS[2020/27]
French:COMPOSITIONS ET MÉTHODES D'ADMINISTRATION D'AGENTS PHARMACOLOGIQUES[2020/27]
Entry into regional phase24.03.2020National basic fee paid 
24.03.2020Search fee paid 
24.03.2020Designation fee(s) paid 
24.03.2020Examination fee paid 
Examination procedure24.03.2020Amendment by applicant (claims and/or description)
24.03.2020Examination requested  [2020/27]
04.01.2022Application deemed to be withdrawn, date of legal effect  [2022/24]
25.01.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/24]
Fees paidRenewal fee
27.08.2020Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.08.202104   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP1944019  (ABRAXIS BIOSCIENCE LLC [US]) [Y] 1-15 * the whole document * * paragraphs [0020] - [0035] - [0 42] , [0 47] , [0 51] , [0 77] , [ 104] , [ 110] , [0111] , [ 112] *;
 [Y]US2017002057  (MO Y JOSEPH [US], et al) [Y] 1-15 * the whole document * * paragraphs [0008] - [0047] - [0 52] *;
 [Y]WO2012051220  (UNIV WICHITA STATE [US], et al) [Y] 1-15 * the whole document *;
 [Y]US2008103213  (KURZROCK RAZELLE [US], et al) [Y] 1-15 * the whole document *;
 [Y]US2010152326  (KURZ DAVID W [US]) [Y] 1-15 * the whole document *;
 [Y]WO2016004048  (BLEND THERAPEUTICS INC [US]) [Y] 1-15 * the whole document *
 [Y]  - I. M. MODLIN ET AL, "Review article: somatostatin analogs in the treatment of gastro-entero-pancreatic neuroendocrine (carcinoid) tumors", ALIMENTARY PHARMACOLOGY & THERAPEUTICS., GB, (20091021), vol. 31, no. 2, doi:10.1111/j.1365-2036.2009.04174.x, ISSN 0269-2813, pages 169 - 188, XP055579096 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1111/j.1365-2036.2009.04174.x
 [Y]  - DING YUEDI ET AL, "The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein inPichia pastoris", JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, BASINGSTOKE, GB, vol. 41, no. 6, doi:10.1007/S10295-014-1440-5, ISSN 1367-5435, (20140422), pages 997 - 1006, (20140422), XP035318227 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1007/s10295-014-1440-5
 [Y]  - DING Y ET AL, "The effect of albumin fusion patterns on the production and bioactivity of the somatostatin-14 fusion protein in Pichia pastoris", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY AUGUST 2013 HUMANA PRESS USA,, (20130801), vol. 170, no. 7, doi:10.1007/S12010-013-0304-1, pages 1637 - 1648, XP002797314 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1007/S12010-013-0304-1
International search[Y]EP1944019  (ABRAXIS BIOSCIENCE LLC [US]) [Y] 1-45 * . entire document *;
 [Y]US2017002057  (MO Y JOSEPH [US], et al) [Y] 1-45 * . entire document *;
 [Y]WO2012051220  (UNIV WICHITA STATE [US], et al) [Y] 3 * . entire document *;
 [Y]US2008103213  (KURZROCK RAZELLE [US], et al) [Y] 30 * . entire document *;
 [Y]US2010152326  (KURZ DAVID W [US]) [Y] 35 * . entire document *;
 [Y]  - MODLIN et al., "Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours", Aliment Pharmacol Ther, (20091021), vol. 31, no. 2, doi:10.1111/j.1365-2036.2009.04174.x, ISSN 0269-2813, pages 169 - 188, XP055579096 [Y] 42 * . entire document *

DOI:   http://dx.doi.org/10.1111/j.1365-2036.2009.04174.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.